Search Results - Datko, Farrah M

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract OT3-09-01: Clinical Trial of Alpelisib and Tucatinib in Patients with PIK3CA-Mutant HER2-Positive Metastatic Breast Cancer

    Abstract OT3-09-01: Clinical Trial of Alpelisib and Tucatinib in Patients with PIK3CA-Mutant HER2-Positive Metastatic Breast Cancer by Shagisultanova, Elena, Wisinski, Kari B., Gawryletz, Chelsea D., Datko, Farrah M., Medgyesy, Diana, Diamond, Jennifer R., Borges, Virginia F., Kabos, Peter

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract PD5-3: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

    Abstract PD5-3: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC) by Shah, Payal D, Moynahan, Mary Ellen, Modi, Shanu, Caravella, Betty Ann, Datko, Farrah M, Zamora, Stephen, Comen, Elizabeth, Gilewski, Theresa, Sugarman, Steven M, D'Andrea, Gabriella, Lake, Diana E, Goldfarb, Shari B, Patil, Sujata, Covey, Anne, Berger, Michael F, Lacouture, Mario E, Norton, Larry, Hudis, Clifford A, Baselga, Jose, Chandarlapaty, Sarat, Dickler, Maura N

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: